SCHEMBL4345702

SCHEMBL4345702

NC(=O)c1cc(-c2cccc(Cl)c2Cl)[nH]c1N

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.47
JAK2 O60674 1/20 0.44
FFAR1 O14842 1/20 0.43
PARP1 P09874 1/20 0.42
ALDH1A1 P00352 2/20 0.41
PKM P14618 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
IKBKB O14920 1/20 0.39
NUDT1 P36639 1/20 0.38
SCN9A Q15858 1/20 0.38
CDC7 O00311 1/20 0.38
BTK Q06187 1/20 0.38
RECQL P46063 1/20 0.38
TSHR P16473 1/20 0.38
ALOX15 P16050 1/20 0.37
SLC9A1 P19634 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339152 0.88 BRD4 (0.52) BRD4JAK2FFAR1PARP1IKBKB
SCHEMBL2198773 0.82 KDM4E (0.44) BRD4JAK2FFAR1PARP1ALDH1A1
SCHEMBL4343087 0.78 JAK2 (0.53) BRD4JAK2ALDH1A1KDM4ECDC7
SCHEMBL4346833 0.76 CDC7 (0.54) BRD4FFAR1PARP1CDC7
SCHEMBL4343078 0.76 BRD4 (0.60) BRD4JAK2FFAR1IKBKBCDC7
SCHEMBL4347846 0.75 BRD4 (0.52) BRD4JAK2KDM4ECDC7
SCHEMBL4355876 0.75 JAK2 (0.53) BRD4JAK2FFAR1PARP1IKBKB
SCHEMBL13446627 0.74 BRD4 (0.45) BRD4PARP1CDC7
SCHEMBL4352604 0.73 ALOX15 (0.45) BRD4JAK2PKMKDM4ECDC7
SCHEMBL27922028 0.73 KEAP1 (0.51) PARP1ALDH1A1PKML3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2116530-B1 NOVEL PYRROLE DERIVATIVE HAVING UREIDE GROUP AND AMINOCARBONYL GROUP AS SUBSTITUENTS SANTEN PHARMACEUTICAL CO LTD (JP) 2012-11-14 EP disclosed
US-7977371-B2 Pyrrole derivative having ureido group and aminocarbonyl group as substituents SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-07-12 US disclosed
US-7977371-B2 Pyrrole derivative having ureido group and aminocarbonyl group as substituents SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-07-12 US disclosed
US-20100099675-A1 NOVEL PYRROLE DERIVATIVE HAVING UREIDO GROUP AND AMINOCARBONYL GROUP AS SUBSTITUENTS SANTEN PHARMACEUTICAL CO., LTD. (JP) 2010-04-22 US disclosed
US-20100099675-A1 NOVEL PYRROLE DERIVATIVE HAVING UREIDO GROUP AND AMINOCARBONYL GROUP AS SUBSTITUENTS SANTEN PHARMACEUTICAL CO., LTD. (JP) 2010-04-22 US disclosed
EP-2116530-A1 NOVEL PYRROLE DERIVATIVE HAVING UREIDE GROUP AND AMINOCARBONYL GROUP AS SUBSTITUENTS Santen Pharmaceutical Co., Ltd (JP) 2009-11-11 EP disclosed
EP-2116530-A1 NOVEL PYRROLE DERIVATIVE HAVING UREIDE GROUP AND AMINOCARBONYL GROUP AS SUBSTITUENTS Santen Pharmaceutical Co., Ltd (JP) 2009-11-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099675-A1 NOVEL PYRROLE DERIVATIVE HAVING UREIDO GROUP AND AMINOCARBONYL GROUP AS SUBSTITUENTS UACA, IL6, IL6ST BRD4 497/4885JAK2 256/4885FFAR1 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.